Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +37.93%
#3 Glidr Glidr +36.87%
#4 MowCat MowCat +27.93%
#5 Humanity Humanity +27.03%
#6 Codatta Codatta +18.91%
#7 Collector Crypt Collector Crypt +18.23%
#8 Walrus Walrus +18.21%
#9 Provenance Blockchain Provenance Blockchain +17.26%
#10 Enso Enso +16.84%
Coin of the day
EXOD EXOD
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Fresh Tracks Therapeutics, Inc. Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc.

FRTX
शेयरों में रैंक #36397
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused... Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engaged in developing next-generation kinase inhibitors. The company maintains crucial licensing and collaborative partnerships, including agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. (and Dr. Nicholas S. Bodor), and AnGes, Inc. Founded in 2009 and based in Boulder, Colorado, the organization rebranded in September 2022, previously operating under the name Brickell Biotech, Inc.
शेयर मूल्य
$0.94
अंतिम समन्वयन: 2025-02-28
मार्केट कैप
$2.73M
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Fresh Tracks Therapeutics, Inc. (FRTX)

श्रेणी

Healthcare
Fresh Tracks Therapeutics, Inc. (FRTX) के लिए बकाया शेयरों की संख्या
December 2023 की स्थिति में बकाया शेयरों की संख्या: 5.91M
Fresh Tracks Therapeutics, Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी के वर्तमान बकाया शेयरों की संख्या 5.91M है। December 2022 के अंत में कंपनी के पास 2.81M बकाया शेयर थे। बकाया शेयरों की संख्या आमतौर पर शेयर स्प्लिट्स और शेयर बायबैक से प्रभावित होती है।
Fresh Tracks Therapeutics, Inc. (FRTX) के लिए 2000 से 2026 तक बकाया शेयरों का इतिहास
प्रत्येक वर्ष के अंत में बकाया शेयर
वर्ष बकाया शेयर परिवर्तन
2026 (TTM) 5.91M 0.00%
2023 5.91M 110.56%
2022 2.81M 57.33%
2021 1.78M 227.63%
2020 544.76K 710.92%
2019 67.18K -3.12%
2018 69.34K 69.47%
2017 40.91K 28.64%
2016 31.81K 9.20%
2015 29.13K 3.33%
2014 28.19K 2.24%
2013 27.57K 1.02%
2012 27.29K 19.35%
2011 22.87K 19.88%
2010 19.07K 27.61%
2009 14.95K 18.14%
2008 12.65K 1.70%
2007 12.44K 24.67%
2006 9.98K 27.89%
2005 7.80K 8.31%
2004 7.20K 12.95%
2003 6.38K 0.06%
2002 6.37K 0.24%
2001 6.36K 1.74%
2000 6.25K 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए बकाया शेयर
कंपनी बकाया शेयर अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 4,194.08%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 951.71%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE